• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳曲酮对接受治疗的酗酒者中线索诱发的渴望的影响。

Naltrexone's effect on cue-elicited craving among alcoholics in treatment.

作者信息

Monti P M, Rohsenow D J, Hutchison K E, Swift R M, Mueller T I, Colby S M, Brown R A, Gulliver S B, Gordon A, Abrams D B

机构信息

Providence VA Medical Center, Brown University, Rhode Island 02912, USA.

出版信息

Alcohol Clin Exp Res. 1999 Aug;23(8):1386-94.

PMID:10470982
Abstract

BACKGROUND

Advancing knowledge of biobehavioral effects of interventions can result in improved treatments. Thus, a standardized laboratory cue reactivity assessment has been developed and validated to assess the cognitive and psychophysiological responses to a simulated high-risk situation: alcohol cues. The present study investigates the effects of a pharmacotherapy (naltrexone) on a laboratory-based, cue-elicited urge to drink among abstinent alcoholics in treatment.

METHODS

Alcohol-dependent subjects were randomized to 12 weeks of naltrexone or placebo after completing a partial hospital program. After approximately 1 week on medication, all received cue reactivity assessment.

RESULTS

Significantly fewer patients taking naltrexone reported any urge to drink during alcohol exposure than did those on placebo. Those with any urges reported no decrement in level of the urges. Mean arterial pressure decreased significantly for those on placebo, but not for those on naltrexone, whereas cue-elicited decreases in heart rate were not affected by the medication.

CONCLUSIONS

The results have implications for models of relapse and naltrexone's effects. Cue reactivity methodology has utility for investigating hypothesized mediators of therapeutic effects of pharmacotherapies as well as behavioral treatments.

摘要

背景

深入了解干预措施的生物行为效应有助于改进治疗方法。因此,已开发并验证了一种标准化的实验室线索反应性评估方法,用于评估对模拟高风险情境(酒精线索)的认知和心理生理反应。本研究调查了药物治疗(纳曲酮)对治疗中戒酒的酒精依赖者基于实验室线索引发的饮酒冲动的影响。

方法

酒精依赖受试者在完成部分住院治疗项目后,被随机分配接受12周的纳曲酮或安慰剂治疗。在服药约1周后,所有受试者均接受线索反应性评估。

结果

与服用安慰剂的患者相比,服用纳曲酮的患者在接触酒精期间报告有饮酒冲动的人数明显较少。有饮酒冲动的患者报告冲动程度没有降低。服用安慰剂的患者平均动脉压显著下降,而服用纳曲酮的患者则没有,线索引发的心率下降不受药物影响。

结论

这些结果对复发模型和纳曲酮的作用具有启示意义。线索反应性方法可用于研究药物治疗以及行为治疗的假设治疗效果中介物。

相似文献

1
Naltrexone's effect on cue-elicited craving among alcoholics in treatment.纳曲酮对接受治疗的酗酒者中线索诱发的渴望的影响。
Alcohol Clin Exp Res. 1999 Aug;23(8):1386-94.
2
Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.纳曲酮与针对酗酒者的应对及沟通技能训练相结合的线索暴露疗法:治疗过程及1年疗效
Alcohol Clin Exp Res. 2001 Nov;25(11):1634-47.
3
Naltrexone's effects on reactivity to alcohol cues among alcoholic men.纳曲酮对酗酒男性酒精线索反应性的影响。
J Abnorm Psychol. 2000 Nov;109(4):738-42.
4
Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.纳曲酮可降低酒精依赖者对酒精的渴望及自我给药量,并激活下丘脑-垂体-肾上腺皮质轴。
Psychopharmacology (Berl). 2002 Feb;160(1):19-29. doi: 10.1007/s002130100919. Epub 2002 Jan 22.
5
The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.纳曲酮在酒精依赖治疗中的地位:对重度饮酒的特定影响。
J Clin Psychopharmacol. 2006 Dec;26(6):610-25. doi: 10.1097/01.jcp.0000245566.52401.20.
6
Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence.联合使用昂丹司琼和纳曲酮可有效治疗具有生物学易感性的酗酒者:从假说到初步临床证据
Alcohol Clin Exp Res. 2000 May;24(5):737-42.
7
Measuring craving: an attempt to connect subjective craving with cue reactivity.测量渴望:将主观渴望与线索反应性联系起来的尝试。
Alcohol Clin Exp Res. 2006 Jan;30(1):57-69. doi: 10.1111/j.1530-0277.2006.00019.x.
8
What role does measuring medication compliance play in evaluating the efficacy of naltrexone?测量药物依从性在评估纳曲酮疗效中起什么作用?
Alcohol Clin Exp Res. 2007 Apr;31(4):596-603. doi: 10.1111/j.1530-0277.2007.00343.x.
9
The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics.纳曲酮和阿坎酸对酒精成瘾者线索诱导的渴望、自主神经系统及对酒精相关线索的神经内分泌反应的影响。
Eur Neuropsychopharmacol. 2007 Jul;17(8):558-66. doi: 10.1016/j.euroneuro.2007.02.012. Epub 2007 Mar 26.
10
High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.高剂量经皮尼古丁与纳曲酮:对尼古丁戒断、渴望、吸烟及吸烟影响的作用
Exp Clin Psychopharmacol. 2007 Feb;15(1):81-92. doi: 10.1037/1064-1297.15.1.81.

引用本文的文献

1
Leveraging meta-regression to test if medication effects on cue-induced craving are associated with clinical efficacy.利用荟萃回归检验药物对线索诱发渴求的影响与临床疗效的相关性。
Psychopharmacology (Berl). 2024 Aug;241(8):1679-1689. doi: 10.1007/s00213-024-06589-7. Epub 2024 Apr 13.
2
Naltrexone engages a brain reward network in the presence of reward-predictive distractor stimuli in males.在存在奖励预测性干扰刺激的情况下,纳曲酮会激活男性大脑中的奖励网络。
Addict Neurosci. 2023 Sep;7. doi: 10.1016/j.addicn.2023.100085. Epub 2023 Apr 2.
3
Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology.
使用线索暴露范式测试酒精使用障碍的药物疗法:人类实验室试验方法的系统评价与定量综合
Alcohol Clin Exp Res (Hoboken). 2023 Sep;47(9):1629-1645. doi: 10.1111/acer.15143. Epub 2023 Jul 23.
4
Blocking μ-opioid receptors attenuates reinstatement of responding to an alcohol-predictive conditioned stimulus through actions in the ventral hippocampus.阻断 μ 阿片受体可通过腹侧海马内的作用减弱对酒精预测性条件刺激的反应重新激发。
Neuropsychopharmacology. 2023 Sep;48(10):1484-1491. doi: 10.1038/s41386-023-01640-1. Epub 2023 Jul 1.
5
Mifepristone as a pharmacological intervention for stress-induced alcohol craving: A human laboratory study.米非司酮作为一种药理学干预手段,用于治疗应激诱导的酒精渴求:一项人体实验室研究。
Addict Biol. 2023 Jul;28(7):e13288. doi: 10.1111/adb.13288.
6
Learning from addiction: Craving of prescription opioids in chronic pain sufferers.从成瘾中学习:慢性疼痛患者对处方类阿片的渴望。
Neurosci Biobehav Rev. 2022 Nov;142:104904. doi: 10.1016/j.neubiorev.2022.104904. Epub 2022 Oct 4.
7
A novel human laboratory alcohol self-administration paradigm for medication screening: Modeling the ability to resist drinking and heavy drinking.一种用于药物筛选的新型人体实验室酒精自我给药范式:模拟抵抗饮酒和酗酒的能力。
Drug Alcohol Depend Rep. 2022 Sep;4. doi: 10.1016/j.dadr.2022.100085. Epub 2022 Aug 13.
8
An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder.一项评估在酒精使用障碍个体中与酒精同时给药时 GET 73 的安全性和耐受性、药代动力学和生物行为效应的住院人体实验室研究。
Psychopharmacology (Berl). 2022 Jan;239(1):35-46. doi: 10.1007/s00213-021-06008-1. Epub 2021 Nov 3.
9
Translational opportunities in animal and human models to study alcohol use disorder.在动物和人类模型中研究酒精使用障碍的转化机会。
Transl Psychiatry. 2021 Sep 29;11(1):496. doi: 10.1038/s41398-021-01615-0.
10
Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.伐尼克兰与纳曲酮联合使用可减弱重度饮酒吸烟者对酒精线索的激活。
Drug Alcohol Depend. 2021 Aug 1;225:108825. doi: 10.1016/j.drugalcdep.2021.108825. Epub 2021 Jun 23.